<DOC>
	<DOC>NCT00377611</DOC>
	<brief_summary>An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™</brief_summary>
	<brief_title>Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<criteria>A male or female age 50 years or older at the time of the first vaccination. nonchildbearing female Availability to follow up by phone Subjects with residence status allowing free mixing with general community Use of nonregistered products Pregnancy Hypersensitivity to a previous dose of influenza vaccine Acute disease at the time of enrolment/vaccination. History of allergy or reactions likely to be exacerbated by any component of the vaccine Any contraindication to intramuscular administration of Fluarix™ For subjects enrolled in the immunogenicity subset only: administration of immunemodifying drugs within 7 days prior to the vaccination</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Influenza vaccine</keyword>
</DOC>